OBERLAND CAPITAL MANAGEMENT LLC
OBERLAND CAPITAL MANAGEMENT LLC is a Series C+ and commercial-stage fund in the US and Europe writing $50M–$300M checks into pharmaceuticals, biotechnology, medical-devices, diagnostics and healthcare-tech.
- Stages
- Series C+, commercial-stage
- Sectors
- pharmaceuticals, biotechnology, medical-devices, diagnostics, healthcare-tech
- Check size
- $50M–$300M
- Invests in
- US-wide, Europe
- Actively investing
- Yes
- Founded
- 2013
- Assets under management
- $3.2B
- Website
- oberlandcapital.com
Thesis
Oberland Capital Management LLC is a private investment firm founded in 2013, specializing in structured financing for global healthcare companies. Their investment thesis centers on clinical-stage and commercial-stage businesses within pharmaceuticals, biotechnology, medical devices, and diagnostics, targeting companies with existing revenue streams. The firm's strategy emphasizes non-dilutive financing solutions like royalty monetizations, revenue-interest agreements, and asset-backed credit facilities, avoiding traditional buyouts or early-stage venture rounds. They aim to provide capital for R&D acceleration, commercial infrastructure expansion, asset acquisition, and refinancing. Operating globally, with transactions in the US and Europe, Oberland Capital managed approximately $3.2 billion in AUM as of year-end 2025. Their third fund, Oberland Capital Healthcare Fund III LP, closed with $1.2 billion in commitments in October 2022.
Common questions
Does OBERLAND CAPITAL MANAGEMENT LLC invest at the Series C+ stage?
Yes. OBERLAND CAPITAL MANAGEMENT LLC lists Series C+ and commercial-stage among the stages it invests in.
What check size does OBERLAND CAPITAL MANAGEMENT LLC write?
OBERLAND CAPITAL MANAGEMENT LLC writes $50M–$300M checks.
Where does OBERLAND CAPITAL MANAGEMENT LLC invest?
OBERLAND CAPITAL MANAGEMENT LLC invests in the US and Europe.